Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Solid Tumor 13 Leukemia, Myeloid, Acute 10 Carcinoma, Non-Small-Cell Lung 7 Advanced Solid Tumors 7 Breast Neoplasms 6 Solid Tumor 5 Pancreatic Neoplasms 5 Melanoma 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Solid Tumors 3 Recurrence 3 Myelodysplastic Syndromes 3 Lung Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Biliary Tract Neoplasms 3 Advanced Malignant Solid Tumor 3 Advanced Lung Cancer 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Prostatic Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Cyclophosphamide 18 fludarabine phosphate 16 Rituximab 16 Etoposide 16 Peripheral Blood Stem Cell Transplantation 14 Brentuximab Vedotin 14 fludarabine 11 Whole-Body Irradiation 11 Nivolumab 11 Mycophenolic Acid 11 Bendamustine Hydrochloride 11 Tacrolimus 10 Melphalan 10 Filgrastim 9 Gemcitabine 8 Carboplatin 8 Ifosfamide 7 Cytarabine 7 Cyclosporine 7 Busulfan 7 pembrolizumab 6 Lenalidomide 6 Doxorubicin 6 Prednisone 5 Everolimus 5 Antilymphocyte Serum 5 Alemtuzumab 5 Vinblastine 4 Methotrexate 4 Mesna 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hodgkin Disease × Injections × Clear all

NCT03343665 2020-01-23

Nivo40

St. Petersburg State Pavlov Medical University

Phase 1/2 Completed

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡